AJO LP’s Pacira BioSciences PCRX Stock Holding History

AJO LP’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,135	Closed	-$205K	–	787
2020 Q1	$205K	Buy	+6,135	New	+$255K	﹤0.01%	559
2019 Q2	–	Sell	-5,655	Closed	-$215K	–	719
2019 Q1	$215K	Buy	+5,655	New	+$221K	﹤0.01%	641

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

AJO LP's PCRX Position: Q2 2020 in Review

AJO LP sold out of Pacira BioSciences (PCRX) in Q2 2020, closing a stake of 6,135 shares — an estimated $205K sold.

AJO LP first reported a position in PCRX in Q1 2019 and held it in 2 quarters. The position peaked at $215K in Q1 2019. 248 funds tracked by Wall St. Rank hold PCRX as of Q2 2020.

AJO LP reported no remaining Pacira BioSciences position as of Q2 2020 after selling out during the quarter.
AJO LP sold 6,135 Pacira BioSciences shares in Q2 2020, an estimated $205K.
AJO LP first reported a position in Pacira BioSciences in Q1 2019 and held it in 2 quarters.
AJO LP's Pacira BioSciences position peaked at $215K in Q1 2019.
248 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2020.

Based on AJO LP's 13F filing for Q2 2020, filed 12 Aug 2020.